Preliminary results from the use of sulfamethoxazole-trimethoprim as prophylaxis after transrectal ultrasound-guided prostate biopsy

Kimiharu Takamatsu, Masaru Ishida, Keishiro Fukumoto, Katsura Ishioka, Masashi Matsushima, Rei Ohara, Michio Kosugi, Yosuke Nakajima

Research output: Contribution to journalArticlepeer-review

Abstract

Because of the increase of fluoroquinorone resistant bacteria after transrectal ultrasound-guided prostate biopsy, we used a single 800 mg/160 mg oral dose of sulfamethoxazole-trimethoprim which has good penetration to the prostate gland. In this study, we investigate the effectiveness of the sulfamethoxazole-trimethoprim as prophylaxis after transrectal ultrasound-guided prostate biopsy. Nine of the 380patients (2.6%) experienced the acute prostatitis. The rate of prostatitis after transrectal ultrasound- guided prostate biopsy in our study is as approximately same as previous reports.

Original languageEnglish
Pages (from-to)400-404
Number of pages5
JournalJapanese Journal of Clinical Urology
Volume69
Issue number5
Publication statusPublished - 2015 Apr 1
Externally publishedYes

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Preliminary results from the use of sulfamethoxazole-trimethoprim as prophylaxis after transrectal ultrasound-guided prostate biopsy'. Together they form a unique fingerprint.

Cite this